Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Gains 6%; BSE HEALTHCARE Index Up 0.6%
Mon, 19 Aug 12:15

Jubilant Pharmova Gains 6%; BSE HEALTHCARE Index Up 0.6%Image source: phive2015/www.istockphoto.com

Jubilant Pharmova share price has zoomed 6% and is presently trading at Rs 898.2.

Meanwhile, the BSE HEALTHCARE index is at 41,408.9 (up 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 11.3%) and AARTI DRUGS (up 5.4%).

SUVEN PHARMACEUTICALS (down 2.7%) and FORTIS HEALTHCARE (down 2.3%) are among the top losers today.

Over the last one year, Jubilant Pharmova has moved up from Rs 431.5 to Rs 898.2, registering a gain of Rs 466.8 (up 108.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 41,408.9, registering a gain of 48.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 127.6%), Jubilant Pharmova (up 108.2%) and GSK Pharma (up 107.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,484.5 (up 0.1%).

The top gainers among the BSE Sensex today are Tata Steel (up 1.4%) and NTPC (up 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,570.0 (up 0.1%). Hindalco and BPCL are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 80,484.5, registering a gain of 15,082.5 points (up 23.1%).

Jubilant Pharmova Financial Update...

Jubilant Pharmova net profit grew 6410.8% YoY to Rs 4,818 million for the quarter ended June 2024, compared to a profit of Rs 74 million a year ago. Net sales rose 9.1% to Rs 17,317 million during the period as against Rs 15,869 million in April-June 2023.

For the year ended March 2024, Jubilant Pharmova reported 212.0% increase in net profit to Rs 727 million compared to net loss of Rs 649 million during FY23. Revenue of the company grew 6.7% to Rs 67,029 million during FY24.

The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 27.4.


Equitymaster requests your view! Post a comment on "Jubilant Pharmova Gains 6%; BSE HEALTHCARE Index Up 0.6%". Click here!